AnaptysBio, Inc. ANAB Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s other commercial liabilities?
- AnaptysBio, Inc. (ANAB) reported other commercial liabilities of $32.07M in Q1 2026.
- How has AnaptysBio, Inc.'s other commercial liabilities changed year-over-year?
- AnaptysBio, Inc.'s other commercial liabilities decreased by 10.8% year-over-year, from $35.95M to $32.07M.
- What is the long-term trend for AnaptysBio, Inc.'s other commercial liabilities?
- Over 5 years (2020 to 2025), AnaptysBio, Inc.'s other commercial liabilities has grown at a 16.4% compound annual growth rate (CAGR), from $15.26M to $32.67M.